Ubenimex (Delta-Fly Pharma)

N/A

Report date: 2024/07/12 09:35:55

Base Information

Drug NameUbenimex (Delta-Fly Pharma)
Drug Alias NameDFP-14323
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunostimulantsLeukotriene A-4 hydrolase inhibitorsAminopeptidase B inhibitors
TargetsLeukotriene A-4 hydrolaseAminopeptidase B
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesDelta-Fly Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesDelta-Fly Pharma Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A